Cigna Group reported first quarter 2026 results: revenue $68.5 billion, net income $1.7 billion, EPS $6.26 per share. Guidance raised.
“The Cigna Group Reports Strong First Quarter 2026 Results, Raises 2026 Outlook • Total revenues for the first quarter 2026 increased 5 % to $68.5 billion • Shareholders’ net income for the first quarter 2026 was $1.7 billion , or $6.26 per share • Adjusted income from operations 1 for the first quarter 2026 was $2.1 billion , or $7.79 per share • 2026 outlook 2 for adjusted income from operations 1,2 increased to at least $30.35 per share 2”
Michael J. Hennigan was appointed as independent director at Cigna Group.
“On May 30, 2025, the board of directors (the “Board”) of The Cigna Group (the “Company”) appointed Michael J. Hennigan as an independent member of the Board, effective June 2, 2025.”
Noelle Eder resigned as Executive Vice President, Global Chief Information Officer at Cigna Group.
“On April 22, 2025, Ms. Noelle Eder, Executive Vice President, Global Chief Information Officer, The Cigna Group, resigned from the Company to pursue another opportunity, effective May 16, 2025.”
Eric P. Palmer resigned as Executive Vice President for Enterprise Strategy, The Cigna Group and President and Chief Executive Officer, Evernorth Health Services at Cigna Group.
“On March 13, 2025, The Cigna Group (the “Company”) filed a Form 8-K disclosing that the employment of Eric P. Palmer, Executive Vice President for Enterprise Strategy, The Cigna Group and President and Chief Executive Officer, Evernorth Health Services, will end April 26, 2025.”
Eric P. Palmer departed as Executive Vice President for Enterprise Strategy at Cigna Group.
“The employment of Eric P. Palmer, Executive Vice President for Enterprise Strategy, The Cigna Group and President and Chief Executive Officer, Evernorth Health Services, will end April 26, 2025.”
Ann M. Dennison was appointed as Executive Vice President, Chief Financial Officer at Cigna Group.
“Ann M. Dennison will serve as Executive Vice President, Chief Financial Officer, The Cigna Group”
Brian C. Evanko changed role as President and Chief Operating Officer at Cigna Group.
“Among these changes, effective March 31, 2025, Brian C. Evanko will serve as President and Chief Operating Officer, The Cigna Group”
Jamie Kates was appointed as Chief Accounting Officer at Cigna Group.
“On June 14, 2024, The Cigna Group (the “Company” or “our”) appointed Jamie Kates as the Company’s Chief Accounting Officer, serving as the Company’s principal accounting officer, effective July 1, 2024.”
Earnings Releases
Cigna Group reported first quarter 2024 results: revenue $57.3 billion, net income $0.3 billion, EPS $0.97 per share. Guidance raised.
“The Cigna Group Reports Strong First Quarter 2024 Results, Raises 2024 Outlook • Total revenues for the first quarter 2024 were $57.3 billion • Shareholders’ net loss for the first quarter 2024 was $0.3 billion, or $0.97 per share”
Shareholder Votes
Cigna Group shareholders rejected Shareholder Proposal – Report to shareholders on risks created by the Company's diversity, equity, and inclusion efforts at the 2024-04-24 meeting.
“Shareholder Proposal – Report to shareholders on risks created by the Company's diversity, equity, and inclusion efforts.”
Shareholder Votes
Cigna Group shareholders rejected Shareholder Proposal – Improve the shareholder right to call a special shareholder meeting at the 2024-04-24 meeting.
“Shareholder Proposal – Improve the shareholder right to call a special shareholder meeting.”
Shareholder Votes
Cigna Group shareholders approved Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group’s independent registered public accounting firm for 2024 at the 2024-04-24 meeting.
“Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group’s independent registered public accounting firm for 2024.”
Shareholder Votes
Cigna Group shareholders approved Advisory approval of The Cigna Group's executive compensation at the 2024-04-24 meeting.
“Advisory approval of The Cigna Group’s executive compensation.”
Shareholder Votes
Cigna Group shareholders approved Election of twelve director nominees for one-year terms at the 2024-04-24 meeting.
“Shareholders elected the twelve director nominees named in the 2024 Proxy Statement for one-year terms to expire at the next annual meeting of shareholders.”
Debt Financings
Cigna Group incurred senior notes of $1.5 billion in aggregate principal amount of its 5.600% Senior Notes due 2054 with U.S. Bank Trust Company, National Association at 5.600% maturing due 2054.
“Company and U.S. Bank Trust Company, National Association, as successor to U.S. Bank National Association, as trustee (the “Trustee”), as supplemented by Supplemental Indenture No.”
Debt Financings
Cigna Group incurred senior notes of $1.25 billion in aggregate principal amount of its 5.250% Senior Notes due 2034 with U.S. Bank Trust Company, National Association at 5.250% maturing due 2034.
“Company and U.S. Bank Trust Company, National Association, as successor to U.S. Bank National Association, as trustee (the “Trustee”), as supplemented by Supplemental Indenture No.”
Debt Financings
Cigna Group incurred senior notes of $750 million in aggregate principal amount of its 5.125% Senior Notes due 2031 with U.S. Bank Trust Company, National Association at 5.125% maturing due 2031.
“Company and U.S. Bank Trust Company, National Association, as successor to U.S. Bank National Association, as trustee (the “Trustee”), as supplemented by Supplemental Indenture No.”
Debt Financings
Cigna Group incurred senior notes of $1.0 billion in aggregate principal amount of its 5.000% Senior Notes due 2029 with U.S. Bank Trust Company, National Association at 5.000% maturing due 2029.
“On February 13, 2024, The Cigna Group (the “Company” or “our”) completed its previously announced offering of $1.0 billion in aggregate principal amount of its 5.000% Senior Notes due 2029”
Material Agreements
Cigna Group entered into Supplemental Indenture No. 7 with U.S. Bank Trust Company, National Association, as successor to U.S. Bank National Association, as trustee (effective 2024-02-13).
“The terms of the Notes are governed by an Indenture, dated as of September 17, 2018 (the “Base Indenture”), between the Company and U.S. Bank Trust Company, National Association, as successor to U.S. Bank National Association, as trustee (the “Trustee”), as supplemented by Supplemental Indenture No. 7 to the Base Indenture, dated as of February 13, 2024 (“Supplemental Indenture No. 7”), between the Company and the Trustee.”
Earnings Releases
Cigna Group updated its the three months and year ended December 31, 2023 guidance (raised).
“On February 2, 2024, The Cigna Group issued a press release announcing results for the three months and year ended December 31, 2023.”
Mary Agoglia Hoeltzel departed as Senior Vice President and Chief Accounting Officer at Cigna Group.
“Mary Agoglia Hoeltzel, Senior Vice President and Chief Accounting Officer, notified The Cigna Group of her intention to retire, effective July 1, 2024.”
Eric P. Palmer was appointed as Executive Vice President, Enterprise Strategy at Cigna Group.
“Eric P. Palmer, currently President and Chief Executive Officer, Evernorth Health Services, will also assume responsibility for enterprise strategy and corporate development in the additional role of the Company’s Executive Vice President for Enterprise Strategy.”
Brian C. Evanko was appointed as President and Chief Executive Officer, Cigna Healthcare at Cigna Group.
“Brian C. Evanko will serve as President and Chief Executive Officer, Cigna Healthcare, in addition to his current role as Executive Vice President and Chief Financial Officer, The Cigna Group.”
Earnings Releases
Cigna Group reported the three months ended September 30, 2023 results: revenue $49,048, net income $1,408, EPS $4.74 per share. Guidance raised.
“1 : Consolidated Financial Results (dollars in millions): Three Months Ended Nine Months Ended September 30, June 30, September 30, 2023 2022 3 2023 2023 Total Revenues $ 49,048 $ 45,281 $ 48,586 $ 144,151 Net Realized Investment Losses from Equity Method Investments 5 30 80 30 22 Adjusted Revenues 5 $ 49,078 $ 45,361 $ 48,616 $ 144,173 Consolidated”
Nicole S. Jones changed role as Executive Vice President, Chief Administrative Officer and General Counsel at Cigna Group.
“Ms. Jones, Executive Vice President, Chief Administrative Officer and General Counsel, now also has responsibility for the Human Resources function”
Noelle K. Eder changed role as Executive Vice President, Technology and Operations at Cigna Group.
“Ms. Eder, Executive Vice President, Technology and Operations, now leads the new Technology and Operations function”
Earnings Releases
Cigna Group reported the three months ended June 30, 2023 results: revenue $48.6 billion, net income $1.5 billion, or $4.92 per share. Guidance reaffirmed.
“The Cigna Group Reports Strong Second Quarter 2023 Results • Total revenues in the second quarter were $48.6 billion • Shareholders’ net income for the second quarter was $1.5 billion, or $4.92 per share • Adjusted income from operations 1 for the second quarter was $1.8 billion, or $6.13 per share • 2023 outlook 2 for adjusted income from operations 1,2 is at least $24.70 per share”
Earnings Releases
Cigna Group reported three months ended March 31, 2023 results: revenue $46.5 billion, net income $1.3 billion, EPS $4.24 per share. Guidance raised.
“The Cigna Group Reports Strong First Quarter 2023 Results, Raises 2023 Outlook • Total revenues in the first quarter were $46.5 billion • Shareholders’ net income for the first quarter was $1.3 billion, or $4.24 per share”
Dr. Philip Ozuah was appointed as Director at Cigna Group.
“On April 26, 2023, the board of directors (the “Board”) of The Cigna Group (the “Company” or “our”) appointed Dr. Philip Ozuah as an independent member of our Board and to the People Resources and Compliance Committees, which appointments are effective June 1, 2023.”
Shareholder Votes
Cigna Group shareholders rejected Shareholder Proposal – Special shareholder meeting improvement at the 2023-04-26 meeting.
“Proposal 6: Shareholder Proposal – Special shareholder meeting improvement. Votes For Votes Against Abstentions Broker Non-Votes 117,434,728 133,649,193 655,660 18,315,429”
Shareholder Votes
Cigna Group shareholders approved Approval of an amendment to our Restated Certificate of Incorporation to limit the liability of certain officers of the Company as permitted pursuant to recent amendments to the Delaware General Corporation Law at the 2023-04-26 meeting.
“Proposal 5: Approval of an amendment to our Restated Certificate of Incorporation to limit the liability of certain officers of the Company as permitted pursuant to recent amendments to the Delaware General Corporation Law. Votes For Votes Against Abstentions Broker Non-Votes 222,860,732 28,396,757 482,092 18,315,429”
Shareholder Votes
Cigna Group shareholders approved Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group's independent registered public accounting firm for 2023 at the 2023-04-26 meeting.
“Proposal 4: Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group’s independent registered public accounting firm for 2023. Votes For Votes Against Abstentions 252,867,500 16,905,824 281,686”
Shareholder Votes
Cigna Group shareholders approved Advisory approval of the frequency of future advisory votes on executive compensation at the 2023-04-26 meeting.
“Proposal 3: Advisory approval of the frequency of future advisory votes on executive compensation. One Year Two Years Three Years Abstentions 247,538,876 179,056 3,654,770 366,879”
Shareholder Votes
Cigna Group shareholders approved Advisory approval of The Cigna Group's executive compensation at the 2023-04-26 meeting.
“Proposal 2: Advisory approval of The Cigna Group’s executive compensation. Votes For Votes Against Abstentions Broker Non-Votes 221,436,565 29,691,242 611,774 18,315,429”
Shareholder Votes
Cigna Group shareholders approved Election of eleven director nominees named in the 2023 Proxy Statement for one-year terms at the 2023-04-26 meeting.
“Proposal 1: Shareholders elected the eleven director nominees named in the 2023 Proxy Statement for one-year terms to expire at the next annual meeting of shareholders.”
Material Agreements
Cigna Group entered into Supplemental Indenture No. 6 with U.S. Bank Trust Company, National Association valued at $700 million...5.685% Senior Notes due 2026 and $800 million...5.400% Senior Notes due 2033 (effective 2023-03-07).
“On March 7, 2023, The Cigna Group (the “Company” or “our”) completed its offering of $700 million in aggregate principal amount of its 5.685% Senior Notes due 2026 (the “2026 Notes”) and $800 million in aggregate principal amount of its 5.400% Senior Notes due 2033 (the “2033 Notes”) (together with the 2026 Notes, the “Notes”).”
Governance Changes
Cigna Group: Amended and restated bylaws to reflect corporate name change (effective 2023-02-13).
“The Company also amended and restated its by-laws (the “Amended and Restated By-laws”) on February 13, 2023 to reflect the Name Change.”
Governance Changes
Cigna Group: Changed corporate name to The Cigna Group via certificate of amendment to restated certificate of incorporation (effective 2023-02-13).
“Effective February 13, 2023, Cigna Corporation (the “Company”) changed its corporate name to The Cigna Group (the “Name Change”) pursuant to a certificate of amendment to the Company’s restated certificate of incorporation (the “Charter Amendment”) previously filed with the Delaware Secretary of State.”
Earnings Releases
Cigna Group reported the fiscal year ending December 31, 2023 results: EPS at least $24.60 per share. Guidance initiated.
“Adjusted income from operations 1,2 is projected to be at least $7.33 billion in 2023, or at least $24.60 per share 2”
Earnings Releases
Cigna Group reported the year ended December 31, 2022 results: revenue $180.5 billion, net income $6.7 billion, EPS $21.30 per share.
“ear 2022 Results, Establishes 2023 Guidance and Increases Dividend • Total revenues for 2022 were $180.5 billion • Shareholders’ net income for 2022 was $6.7 billion, or $21.30 per share • Adjusted income from”
Earnings Releases
Cigna Group reported the three months ended December 31, 2022 results: revenue $45,751, net income $1,169, EPS $3.83.
“Consolidated Financial Results (dollars in millions): Three Months Ended Year Ended December 31, December 31, 2022 2021 2022 2021 Total Revenues $ 45,751 $ 45,688 $ 180,516 $ 174,078”
Earnings Releases
Cigna Group reported quarter ended September 30, 2022 results: revenue 45.3 billion, net income 2.8 billion, EPS 8.97.
“Total revenues in the third quarter were $45.3 billion • Shareholders’ net income for the third quarter was $2.8 billion, or $8.97 per share”
“On October 26, 2022, in connection with the new Securities and Exchange Commission rules regarding universal proxy cards and certain recent changes to the Delaware General Corporation Law (the “DGCL”), the Board of Directors of Cigna Corporation (the “Company”) unanimously adopted Restated By-Laws of Cigna Corporation (the by-laws, as restated, the “Restated By-Laws”), effective immediately. The Restated By-Laws, among other things: • Update the procedural mechanics for stockholder nominations of directors to address matters relating to Rule 14a-19 under the Securities Exchange Act of 1934, as amended; • Modify the provisions relating to adjournment procedures and lists of stockholders entitled to vote at stockholder meetings, in each case to reflect recent amendments to the DGCL; and • Make various other ministerial and conforming changes.”
Eric P. Palmer was appointed as President and Chief Executive Officer, Evernorth at Cigna Group.
“On September 23, 2021, the Company announced the appointment of Eric P. Palmer as President and Chief Executive Officer, Evernorth, effective January 1, 2022.”
Timothy C. Wentworth departed as Chief Executive Officer, Evernorth at Cigna Group.
“Timothy C. Wentworth, Chief Executive Officer, Evernorth, notified Cigna Corporation (the “Company”) of their intention to retire, effective December 3, 2021 and December 31, 2021, respectively.”
Matthew G. Manders departed as President, Government & Solutions at Cigna Group.
“Matthew G. Manders, President, Government & Solutions, and Timothy C. Wentworth, Chief Executive Officer, Evernorth, notified Cigna Corporation (the “Company”) of their intention to retire, effective December 3, 2021 and December 31, 2021, respectively.”
Neesha Hathi was appointed as independent member of the Board at Cigna Group.
“On July 28, 2021, the Board appointed Neesha Hathi as an independent member of the Board, such appointment to be effective as of September 1, 2021.”
Isaiah Harris, Jr. departed as Chair of the Board of Directors at Cigna Group.
“On July 26, 2021, Isaiah Harris, Jr., the current Chair of the Board of Directors (the “Board”) of Cigna Corporation (“Cigna” or the “Company”), informed the Board that he intends to retire at the end of the year.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.